Company / Accounts Receivable
Ensign Group Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$637.0M
FY2025
5-year range
$328.7M / $637.0M
FY2021-FY2025
Trend
+11.8%
vs FY2024
Sector context
#37 of 138
Health Care
What the data says
At $637M, Ensign Group's accounts receivable ranks #37 of 138 in the Health Care sector. Accounts Receivable has increased for 5 consecutive years, from $305M in FY2020 to $637M in FY2025.
Based on SEC 10-K filings.
$637M in FY2025 with a 5-year CAGR of +15.9%.
Improved from $485M to $637M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +15.9%
- 10-Year CAGR
- -
Sector benchmark
#37 of 138 in Health CareTop 27% of 138This company $637.0M Sector average $1.3B
▼
-51.8% below sector average
Key checks
Key Insights
- Ensign Group's accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +15.9%, indicating consistent growth.
- In FY2025, accounts receivable increased 11.8% year-over-year.
- Ranks #37 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $637.0M | +11.8% |
| FY2024 | $569.9M | +17.5% |
| FY2023 | $485.0M | +18.8% |
| FY2022 | $408.4M | +24.2% |
| FY2021 | $328.7M | +7.8% |
| FY2020 | $305.1M | -1.3% |
| FY2019 | $309.0M | +22.7% |
| FY2018 | $251.9M | -5.0% |
| FY2017 | $265.1M | +8.4% |
| FY2016 | $244.4M | +16.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026